123 related articles for article (PubMed ID: 7295159)
1. Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor.
Panje WR
Arch Otolaryngol; 1981 Nov; 107(11):658-63. PubMed ID: 7295159
[TBL] [Abstract][Full Text] [Related]
2. Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck.
Cross DS; Platt JL; Juhn SK; Bach FH; Adams GL
Arch Otolaryngol Head Neck Surg; 1992 May; 118(5):526-8. PubMed ID: 1571128
[TBL] [Abstract][Full Text] [Related]
3. Immunostimulation of patients with head and neck cancer. In vitro and preliminary clinical experiences.
Hirsch B; Johnson JT; Rabin BS; Thearle PB
Arch Otolaryngol; 1983 May; 109(5):298-301. PubMed ID: 6847479
[TBL] [Abstract][Full Text] [Related]
4. Tumor infiltrating lymphocytes in squamous cell carcinoma of the head and neck: mechanisms of enhancement using prostaglandin synthetase inhibitors.
Cross DS; Platt JL; Juhn SK; Bach FH; Adams GL
Adv Exp Med Biol; 1997; 400B():1013-24. PubMed ID: 9547657
[TBL] [Abstract][Full Text] [Related]
5. Subrenal capsule assay for squamous cell carcinoma of the head and neck.
Stiernberg CM; Rotzler WH; Valyi-Nagy K; Hokanson JA; Hale PE
Otolaryngol Head Neck Surg; 1986 Sep; 95(2):177-81. PubMed ID: 3108755
[TBL] [Abstract][Full Text] [Related]
6. Comparison of in vivo and in vitro prostaglandin E2 production by squamous cell carcinoma of the head and neck.
Snyderman CH; Klapan I; Milanovich M; Heo DS; Wagner R; Schwartz D; Johnson JT; Whiteside TL
Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 1):189-96. PubMed ID: 8084624
[TBL] [Abstract][Full Text] [Related]
7. [Experiences with simultaneous cytostatic and radiotherapy treatment of advanced cancer of the head and neck].
Ehr R; Richter E
Laryngorhinootologie; 1990 Jun; 69(6):312-5. PubMed ID: 2378657
[TBL] [Abstract][Full Text] [Related]
8. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis.
Zhang DY; Wu J; Ye F; Xue L; Jiang S; Yi J; Zhang W; Wei H; Sung M; Wang W; Li X
Cancer Res; 2003 Jul; 63(14):4037-43. PubMed ID: 12874003
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound of the abdomen and total bone scintigraphy in patients with cancer of the head and neck.
Lybak S; Olofsson J
Eur Arch Otorhinolaryngol; 2005 Nov; 262(11):887-9. PubMed ID: 16273413
[TBL] [Abstract][Full Text] [Related]
12. Radionuclide scans in the assessment of distant metastases from squamous cell carcinoma of the head and neck.
Martin GF; Gullane PJ; Heeneman H
J Otolaryngol; 1981 Oct; 10(5):383-6. PubMed ID: 7328722
[TBL] [Abstract][Full Text] [Related]
13. Some mechanisms of local bone destruction by squamous carcinomas of the head and neck.
Tsao SW; Burman JF; Easty DM; Easty GC; Carter RL
Br J Cancer; 1981 Mar; 43(3):392-401. PubMed ID: 7225288
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of head and neck tumor cell growth with arachidonic acid metabolism inhibition.
Ondrey FG; Juhn SK; Adams GL
Laryngoscope; 1996 Feb; 106(2 Pt 1):129-34. PubMed ID: 8583839
[TBL] [Abstract][Full Text] [Related]
15. Sequential methotrexate-5-fluorouracil treatment of squamous cell carcinoma of the head and neck.
Ringborg U; Ewert G; Kinnman J; Lundqvist PG; Strander H
Cancer; 1983 Sep; 52(6):971-3. PubMed ID: 6603896
[TBL] [Abstract][Full Text] [Related]
16. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
Mantovani G; Ghiani M; Lai P; Maccio A; Dessi D; Succu G; Massa D; Curreli L; Mulas C; Esu S; Proto E; Cadeddu G; Tore G
Oncol Rep; 1998; 5(6):1499-505. PubMed ID: 9769395
[TBL] [Abstract][Full Text] [Related]
18. Plasma prostaglandins in mucositis due to radiotherapy and chemotherapy for head and neck cancer.
Tanner NS; Stamford IF; Bennett A
Br J Cancer; 1981 Jun; 43(6):767-71. PubMed ID: 7248158
[TBL] [Abstract][Full Text] [Related]
19. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH
Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.
Merlano M; Russi EG; Numico G; Colantonio I; Garrone O; Pelissero A; Granetto C; Gasco M; Di Costanzo G; Heouaine A; Vigna Taglianti R; Cipolat M
Radiother Oncol; 2005 May; 75(2):193-6. PubMed ID: 16086909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
